Anti-human claudin 18.2 monoclonal antibody and application thereof
A monoclonal antibody, antibody technology, applied in the field of biomedicine, can solve the problems of reduced expression, no antibody yet, reduced expression of claudin-18, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0092] 1. Antigen Preparation
[0093] GST-ECD protein preparation
[0094] The partial sequence of the first extracellular domain of human claudin 18.2 was constructed on the pGEX-KG vector (antigen sequence 1), the constructed expression vector was transformed into E. coli TG1 strain, cultured in LB medium and induced by IPTG expression of antigenic proteins. The collected E. coli TG1 cells were crushed with a homogenizer, affinity purified with GlutathioneSepharose 4 Fast Flow (GE, Cat# 17-5132-01), and then purified with HiTrap Capto Q (GE, Cat# 11001302) ) column for secondary purification and dialyzed the protein into PBS, pH 7.4 to obtain the antigenic protein with a purity of >85%.
[0095] DNA immunogen preparation
[0096] The partial or full-length sequence of the first extracellular domain of claudin 18.2 was constructed on the pcDNA3.1 vector as an immunogen (antigen sequence 2, antigen sequence 3).
[0097] Human claudin 18.1 and human claudin 18.2 stable cel...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com